Skip to main content

Advertisement

SpringerLink
Log in

Routine preoperative 111In-octreotide scintigraphy in patients with medullary thyroid cancer

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Surgery is the only potential cure for patients with medullary thyroid carcinoma (MTC). Preoperative ultrasound, computed tomography and magnetic resonance imaging are not sensitive enough for detection of microscopic disease. The aim of this study was to investigate if routine preoperative 111In-labelled (DTPA-D-Phe1)-octreotide scintigraphy (SRS) could be used as a staging procedure in planning primary surgery in patients with MTC.

Methods

This study included patients with primary sporadic clinically overt MTC diagnosed between 1996 and 2009. All patients underwent conventional imaging of neck and thorax and SRS prior to standardised surgery. The findings on SRS were correlated to the findings on conventional imaging, histopathology and to postoperative biochemical results and survival.

Results

A total of 19 patients with sporadic MTC were enrolled. Median follow-up was 77(9–184) months. SRS visualised the primary tumour in 16 (84 %) patients. Fifteen (79 %) patients had locoregional lymph node metastases, but SRS detected metastatic lesions in only 8 (53 %) patients. In three patients with distant spread, SRS failed to detect metastatic lesions in two. At latest follow-up, six (32 %) patients had died, nine (47 %) patients were alive with elevated tumour markers, and four (21 %) patients were considered in complete biochemical remission.

Conclusions

This study provided further evidence that SRS, compared to conventional imaging, is fairly sensitive for detection of primary MTC but not metastatic disease. Although preoperative SRS may be of prognostic value, there is no indication for its routine use as a staging procedure in planning primary surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 6:880–887

    Article  Google Scholar 

  2. Fleming JB, Lee JE, Bouvet M et al (1999) Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg 5:697–707

    Article  Google Scholar 

  3. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 6:562–567

    Article  Google Scholar 

  4. Machens A, Hauptmann S, Dralle H (2007) Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer. World J Surg 10:1960–1965

    Article  Google Scholar 

  5. Busnardo B, Girelli NE, Simioni N et al (1984) Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. Cancer 53:278–285

    Article  PubMed  CAS  Google Scholar 

  6. Papotti M, Kumar U, Volante M et al (2001) Immunohistochemical detection of somatostatin receptor types 1–5 in medullary carcinoma of the thyroid. Clin Endocrinol 5:641–649

    Article  Google Scholar 

  7. Tisell LE, Ahlman H, Wängberg B et al (1997) Somatostatin receptor scintigraphy in medullary thyroid carcinoma. Br J Surg 4:543–547

    Article  Google Scholar 

  8. Kaltsas G, Rockall A, Papadogias D et al (2004) Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 1:15–27

    Article  Google Scholar 

  9. Baudin E, Lumbroso J, Schlumberger M et al (1996) Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med 6:912–916

    Google Scholar 

  10. Kwekkeboom DJ, Reubi JC, Lamberts SW et al (1993) In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab 6:1413–1417

    Article  Google Scholar 

  11. Dörr U, Frank-Raue K, Raue F et al (1993) The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma. Nucl Med Commun 6:439–445

    Google Scholar 

  12. Lodish M, Dagalakis U, Chen CC et al (2012) (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents. J Clin Endocrinol Metab 2:207–212

    Article  Google Scholar 

  13. TNM classification of malignant tumours (2009) Wiley-Liss, New York

  14. Faggiano A, Grimaldi F, Pezzullo L et al (2009) Secretive and proliferative tumour profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer. Endocr Relat Cancer 1:225–231

    Google Scholar 

  15. Giraudet AL, Vanel D, Leboulleux S et al (2007) Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 11:4185–4190

    Article  Google Scholar 

  16. Reubi JC, Krenning E, Lamberts SW et al (1992) In vitro detection of somatostatin receptors in human tumours. Metabolism 9(Suppl 2):104–110

    Article  Google Scholar 

  17. Christian JA, Cook GJ, Harmer C (2003) Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid. Br J Cancer 2:258–261

    Article  Google Scholar 

  18. Mato E, Matías-Guiu X, Chico A et al (1998) Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. J Clin Endocrinol Metab 7:2417–2420

    Article  Google Scholar 

  19. Forssell-Aronsson EB, Nilsson O, Bejegård SA et al (2000) 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumours. J Nucl Med 4:636–642

    Google Scholar 

  20. Reubi JC, Chayvialle JA, Franc B et al (1991) Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 4:567–573

    Google Scholar 

  21. Behr TM, Gratz S, Markus PM et al (1997) Anti-carcinoembryonic antigen antibodies versus somatostatin analogues in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors? Cancer 80(12 Suppl):2436–2457

    Article  PubMed  CAS  Google Scholar 

  22. Grebe SKG, Hay ID (1996) Thyroid nodal metastases, biologic significance and therapeutic considerations. Surg Oncol Clin North Am 5:43–64

    CAS  Google Scholar 

  23. Tisell LE, Oden A, Muth A et al (2003) The Ki67 index a prognostic marker in medullary thyroid carcinoma. Br J Cancer 11:2093–2097

    Article  Google Scholar 

  24. Reubi JC, Waser B (1996) Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas. Int J Cancer 5:644–647

    Article  Google Scholar 

  25. Gotthardt M, Béhé MP, Beuter D et al (2006) Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 11:1273–1279

    Article  Google Scholar 

  26. Fröberg AC, de Jong M, Nock BA et al (2009) Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 8:1265–1272

    Article  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Surgery, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden

    Jakob Dahlberg, Per Bümming & Svante Jansson

  2. Department of Clinical Physiology, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden

    Peter Gjertsson

Authors
  1. Jakob Dahlberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Per Bümming
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Gjertsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Svante Jansson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jakob Dahlberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dahlberg, J., Bümming, P., Gjertsson, P. et al. Routine preoperative 111In-octreotide scintigraphy in patients with medullary thyroid cancer. Langenbecks Arch Surg 398, 875–880 (2013). https://doi.org/10.1007/s00423-013-1086-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-013-1086-1

Keywords

Search

Navigation